Paper72598
Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ and 2 others. Cancer Res, 1977. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Surface antigenic characteristics of human glial brain tumor cells. Papers, record 72598. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/72598
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Brain Neoplasms | Major topic |
| Glioma | Major topic |
| Antibodies, Neoplasm | |
| Antibody Specificity | |
| Cell Line | |
| Cell Membrane | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Fluorescent Antibody Technique | |
| HLA Antigens | |
| Humans | |
| Neoplasms, Experimental | |
| Niacinamide |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27310018 | BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. | PLoS One | 2016 | https://conductscience.org/library/papers/27310018 | PubMed |
| 19591631 | The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. | Expert Opin Biol Ther | 2009 | https://conductscience.org/library/papers/19591631 | PubMed |
| 18539480 | Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma. | Semin Immunol | 2008 | https://conductscience.org/library/papers/18539480 | PubMed |
| 18363995 | Immunotherapy of malignant brain tumors. | Immunol Rev | 2008 | https://conductscience.org/library/papers/18363995 | PubMed |
| 11775071 | Establishment and partial characterization of a continuous human malignant glioma cell line: NG97. | Cell Mol Neurobiol | 2001 | https://conductscience.org/library/papers/11775071 | PubMed |
| 7211194 | Characterization of an established human malignant glioma cell line: LN-18. | Acta Neuropathol | 1981 | https://conductscience.org/library/papers/7211194 | PubMed |
| 7015802 | Immunohistochemical demonstration of IgG in meningioma. | Acta Neurochir (Wien) | 1981 | https://conductscience.org/library/papers/7015802 | PubMed |
| 6986786 | Immunobiologic aspects of the brain and human gliomas. A review. | Am J Pathol | 1980 | https://conductscience.org/library/papers/6986786 | PubMed |
| 6381659 | Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671. | J Neurooncol | 1984 | https://conductscience.org/library/papers/6381659 | PubMed |
| 6090602 | Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study. | J Neurooncol | 1984 | https://conductscience.org/library/papers/6090602 | PubMed |
| 3966985 | A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3966985 | PubMed |
| 3890235 | The immunobiology of human gliomas. | Springer Semin Immunopathol | 1985 | https://conductscience.org/library/papers/3890235 | PubMed |
| 3494820 | Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor. | J Neurooncol | 1987 | https://conductscience.org/library/papers/3494820 | PubMed |
| 3279793 | Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. | Am J Pathol | 1988 | https://conductscience.org/library/papers/3279793 | PubMed |
| 3090477 | Immunobiology of brain tumors. | Neurosurg Rev | 1986 | https://conductscience.org/library/papers/3090477 | PubMed |
| 2660987 | Immunology of gliomas. | Childs Nerv Syst | 1989 | https://conductscience.org/library/papers/2660987 | PubMed |
| 2609939 | GD3 expression by cultured human tumor cells of neuroectodermal origin. | Acta Neuropathol | 1989 | https://conductscience.org/library/papers/2609939 | PubMed |
| 1659106 | Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas. | Acta Neuropathol | 1991 | https://conductscience.org/library/papers/1659106 | PubMed |
| 518297 | Growth of measles virus in continuous cell lines derived from the nervous tissues of human and rat. | Arch Virol | 1979 | https://conductscience.org/library/papers/518297 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/72598
GET https://conductscience.org/api/papers/v1/72598/authors